FDA panel takes up tough questions on J&J COVID-19 boosters

WASHINGTON (AP) – U.S. health advisers on Friday tackled who should get boosters of Johnson & Johnson’s single-shot COVID-19 vaccine and when - and whether using a competing brand for the second dose might provide better protection.

The push for boosters kicked off last month after the Food and Drug ...

from The Washington Times stories: Health https://ift.tt/3mZeDnS

Post a Comment

Previous Post Next Post